Wealth Advisory Solutions’s Gilead Sciences GILD Stock Holding History

Wealth Advisory Solutions’s Portfolio GILD Stock Details GILD Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	$220K	Sell	1,576 -132	-8%	-$18.5K	0.05%	132
2025 Q4	$210K	Buy	+1,708	New	+$208K	0.05%	135
2022 Q3	–	Sell	-3,252	Closed	-$201K	–	139
2022 Q2	$201K	Buy	+3,252	New	+$201K	0.05%	141
2020 Q3	–	Sell	-2,847	Closed	-$219K	–	182
2020 Q2	$219K	Sell	2,847 -857	-23%	-$65.7K	0.06%	167
2020 Q1	$276K	Buy	3,704 +291	+9%	+$20.1K	0.09%	135
2019 Q4	$221K	Buy	+3,413	New	+$222K	0.06%	168

Other funds holding GILD

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

VCM

Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return

Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return

VPM

Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return

Wealth Advisory Solutions's GILD Position: Q1 2026 in Review

Wealth Advisory Solutions reduced its Gilead Sciences (GILD) stake by 7.7% in Q1 2026, selling an estimated $18.5K and leaving 1,576 shares worth $220K. The position accounts for 0.05% of the portfolio, ranked #132.

Wealth Advisory Solutions first reported a position in GILD in Q4 2019 and has held it in 6 quarters since. The position peaked at $276K in Q1 2020. 2,309 funds tracked by Wall St. Rank hold GILD as of Q1 2026.

Wealth Advisory Solutions held 1,576 shares of Gilead Sciences worth $220K as of Q1 2026.
Wealth Advisory Solutions sold 132 Gilead Sciences shares in Q1 2026, an estimated $18.5K.
Gilead Sciences made up 0.05% of Wealth Advisory Solutions's portfolio in Q1 2026, its #132 holding.
Wealth Advisory Solutions first reported a position in Gilead Sciences in Q4 2019 and has held it in 6 quarters since.
Wealth Advisory Solutions's Gilead Sciences position peaked at $276K in Q1 2020.
2,309 funds tracked by Wall St. Rank held Gilead Sciences as of Q1 2026.

Based on Wealth Advisory Solutions's 13F filing for Q1 2026, filed 22 Apr 2026.